Regulatory change

Refining relabeling of pharmaceuticals

Patient safety is at the heart of drug development and licensing processes. But the duty of care does not stop at launch. Manufacturers must satisfy strict regulatory demands throughout a product’s lifecycle, including re-labeling.
1

Swiss Financial Market: Regulatory Outlook 2015

Regulatory bodies all over the world continue to address issues that became apparent in the financial crisis. The beginning of the New Year is a good point in time to take stock of the regulations that has entered into force on 1 January 2015, and of regulations in discussion during 2015.
13

Evolving Insurance Regulation

Regulatory change is fundamentally re-shaping the global insurance industry, creating strategic and operational challenges for insurers.
13